UC Riverside granted $5 million for stem cell research training
A $5 million grant will be used to train students in stem cell research to contribute towards new stem cell-based therapeutics.
List view / Grid view
A $5 million grant will be used to train students in stem cell research to contribute towards new stem cell-based therapeutics.
A genetic defect in patients with inflammatory bowel disease (IBD) was found to affect how intestinal epithelial cells maintain a barrier.
A drug screen using machine learning has identified hundreds of potential drugs that could be used to treat COVID-19, researchers say.
A study has revealed the structure of an enzyme that promotes cancer growth by mutating RNA, which could be used in the development of cancer treatments.
A new approach to targeting cancer cells that circumvents a challenge faced by currently available cancer drugs has been developed.
Long-term goal is to develop treatments that prevent cancer cells from attaching to new sites during metastasis.